Evidence map›Paper›PMID 29798884›Full record

ArticleScience (New York, N.Y.)2018

An ingestible bacterial-electronic system to monitor gastrointestinal health.

Mark Mimee, Phillip Nadeau, Alison Hayward, Sean Carim, Sarah Flanagan, Logan Jerger, Joy Collins, Shane McDonnell, Richard Swartwout, Robert J Citorik and 5 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 226 papers.

0numbers the graph read from it
0cells of the map it votes in
226citing papers in PubMed
24.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

226 citing papers in PubMed, 583 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Programming Next-Generation Synthetic Biosensors by Genetic Circuit Design.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  19. Review
  20. Article

166 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Mark Mimee *Microbiology Program, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA.ORCID 0000-0002-3083-2671
Phillip Nadeau *Department of Electrical Engineering and Computer Science, MIT, Cambridge, MA 02139, USA.ORCID 0000-0002-7820-1625
Alison HaywardDivision of Comparative Medicine, MIT, Cambridge, MA 02139, USA.ORCID 0000-0002-9581-8563
Sean CarimSynthetic Biology Center, MIT, Cambridge, MA 02139, USA.ORCID 0000-0002-3189-5762
Sarah FlanaganDepartment of Electrical Engineering and Computer Science, MIT, Cambridge, MA 02139, USA.ORCID 0000-0002-9246-6881
Logan JergerSynthetic Biology Center, MIT, Cambridge, MA 02139, USA.
Joy CollinsKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA.ORCID 0000-0002-9232-4517
Shane McDonnellKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA.ORCID 0000-0001-8010-0113
Richard SwartwoutDepartment of Electrical Engineering and Computer Science, MIT, Cambridge, MA 02139, USA.ORCID 0000-0003-1603-3491
Robert J CitorikMicrobiology Program, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA.ORCID 0000-0002-6397-5417
Vladimir BulovićDepartment of Electrical Engineering and Computer Science, MIT, Cambridge, MA 02139, USA.
Robert LangerKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA.ORCID 0000-0003-4255-0492
Giovanni TraversoKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA.ORCID 0000-0001-7851-4077
Anantha P ChandrakasanDepartment of Electrical Engineering and Computer Science, MIT, Cambridge, MA 02139, USA. timlu@mit.edu anantha@mtl.mit.edu.
Timothy K LuSynthetic Biology Center, MIT, Cambridge, MA 02139, USA. timlu@mit.edu anantha@mtl.mit.edu.ORCID 0000-0002-3918-8923
IIT@MIT · USAllen Institute · USBoston Children's Hospital · USBrigham and Women's Hospital · US

Funding

MIT Center for Integrative Synthetic BiologyP50GM098792 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WEISS, RON · 2013 to 2017
$11.0M
CONTROLLED RELEASE OF MACROMOLECULESR01EB000244 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LANGER, ROBERT SAMUEL, TRAVERSO, CARLO GIOVANNI · 2002 to 2021
$6.1M
Controlled Release of MacromoleculesR37EB000244 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LANGER, ROBERT SAMUEL · 2008 to 2017
$3.9M
NIBIB NIH HHS R01 EB000244NIBIB NIH HHS R37 EB000244NIGMS NIH HHS P50 GM098792
6 · The paper itself

Abstract

Biomolecular monitoring in the gastrointestinal tract could offer rapid, precise disease detection and management but is impeded by access to the remote and complex environment. Here, we present an ingestible micro-bio-electronic device (IMBED) for in situ biomolecular detection based on environmentally resilient biosensor bacteria and miniaturized luminescence readout electronics that wirelessly communicate with an external device. As a proof of concept, we engineer heme-sensitive probiotic biosensors and demonstrate accurate diagnosis of gastrointestinal bleeding in swine. Additionally, we integrate alternative biosensors to demonstrate modularity and extensibility of the detection platform. IMBEDs enable new opportunities for gastrointestinal biomarker discovery and could transform the management and diagnosis of gastrointestinal disease.

Indexed as

ProbioticsAnimalsBiosensing TechniquesElectrical Equipment and SuppliesGastrointestinal DiseasesGastrointestinal HemorrhageGastrointestinal TractHemeMonitoring, PhysiologicSwineHeme

Identifiers

PMID29798884
PMCPMC6430580
OpenAlexW2803662842

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.